HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Cancer treatment during pregnancy ‘a constant balancing act’
-
- Neoadjuvant studies can demonstrate value of new agents in breast cancer Douglas Yee, MD
- Memorial Sloan Kettering named best cancer hospital on U.S. News & World Report list
- All-new Healio.com is designed by you and is ready for its close-up
- The changing face of our major meetings: Evolution or revolution? John Sweetenham, MD, FRCP, FACP
- FDA approves DNA stool test for colon cancer
- Exemestane had limited negative effect on QOL for postmenopausal women at risk for breast cancer
- Pemetrexed plus cisplatin active in advanced, recurrent cervical carcinoma
- Trastuzumab associated with durable EFS in HER-2–positive breast cancer
-
- False-positive lung cancer screening results did not affect anxiety, quality of life
- Lower radiation doses, smaller boost volumes minimized intellectual decline in medulloblastoma
- MRD-directed therapy improved outcomes in pediatric BCR-ABL1–like ALL
- Diabetes increased risk for head, neck cancers
- High-dose melphalan plus salvage ASCT improved outcomes in relapsed myeloma
- Unprovoked VTE, thrombosis at young age increased risk among first-degree relatives
- Antiviral therapy improved outcomes in HCV-related indolent NHL
- Area poverty rate linked to incidence of certain cancers
-
- Chromosomal instability predicted favorable chemoradiation response in rectal adenocarcinoma
- HLA-matched donors available for most HSCT candidates
- Lenalidomide plus R-CHOP21 safe, effective in elderly patients with DLBCL
- LMWH did not reduce complications in pregnant women with thrombophilia
- Long-term survival rates high for pediatric low-grade gliomas
- Management of low-risk prostate cancer varied greatly by physician
- Melanoma risk increased in men who took sildenafil
- Papillary thyroid cancer, melanoma demonstrated related risks
-
- Radium Ra 223 dichloride safe, effective for prostate cancer bone metastases
- Regular aspirin use reduced risk for pancreatic cancer
- Study identifies link between gut bacteria, post-SCT survival
- ACP: Average-risk women should not undergo routine pelvic exams
- Chemotherapy superior to TKIs in advanced, EGFR wild-type NSCLC
- Everolimus failed to improve OS in advanced HCC
- AACR announces board appointments
- Surgical oncologist joins cancer center
-
- Surgical oncologist named university head and neck department chair